Current Assets
Income taxes receivable
Idexx Laboratories Income taxes receivable decreased by 75.4% to $15.97M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 16.1%, from $13.76M to $15.97M. Over 5 years (FY 2020 to FY 2025), Income taxes receivable shows an upward trend with a 59.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalHigher is better
VolatilityModerate
First reportedQ4 2014
Last reportedQ1 2026
How to read this metric
An increase may indicate overpayment of estimated taxes or the accrual of refundable credits, representing a potential source of near-term cash inflow.
Detailed definition
This represents the amount of income tax overpayments or refundable tax credits that the company expects to recover from...
Peer comparison
Common for large corporations that manage complex tax filings across multiple jurisdictions.
Metric ID:
income_taxes_receivableHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.45M | $2.45M | $1.81M | $2.36M | $361.00K | $539.00K | $48.43M | $1.55M | $1.55M | $18.21M | $16.97M | $14.46M | $15.99M | $14.41M | $26.99M | $13.76M | $35.00M | $76.13M | $64.99M | $15.97M |
| QoQ Change | — | +0.0% | -26.3% | +30.6% | -84.7% | +49.3% | >999% | -96.8% | +0.0% | >999% | -6.8% | -14.8% | +10.6% | -9.9% | +87.4% | -49.0% | +154.4% | +117.6% | -14.6% | -75.4% |
| YoY Change | — | — | — | — | -85.3% | -78.0% | >999% | -34.4% | +328.8% | >999% | -65.0% | +834.0% | +932.8% | -20.9% | +59.0% | -4.9% | +118.9% | +428.5% | +140.8% | +16.1% |
Range$361.00K – $76.13M
CAGR+48.4%
Avg YoY Growth+526.9%
Median YoY Growth+89.0%
Current Streak2 quarters decline
Income taxes receivable at Other Companies
Frequently Asked Questions
- What is Idexx Laboratories's income taxes receivable?
- Idexx Laboratories (IDXX) reported income taxes receivable of $15.97M in Q1 2026.
- How has Idexx Laboratories's income taxes receivable changed year-over-year?
- Idexx Laboratories's income taxes receivable increased by 16.1% year-over-year, from $13.76M to $15.97M.
- What is the long-term trend for Idexx Laboratories's income taxes receivable?
- Over 5 years (2020 to 2025), Idexx Laboratories's income taxes receivable has grown at a 59.3% compound annual growth rate (CAGR), from $6.33M to $64.99M.
- What does income taxes receivable mean?
- Tax refunds or credits owed to the company by government tax agencies.